Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

CEL-SCI: Food For Thought Before The Big Day [Seeking Alpha]

Cel-Sci Corporation (CVM) 
NASDAQ:AMEX Investor Relations: cel-sci.com/investor_relations.html
Company Research Source: Seeking Alpha
Summary CEL-SCI is extremely likely to witness clinical trial success with its only product, Multikine. More than 350,000 patients die each year due to HSNCC. The drug has a total addressable market of over $2.0 billion in the U.S. alone. Top line data are anticipated by the end of April. CEL-SCI does not have to raise further cash to fund development efforts. Company Thesis Over the years, CEL-SCI Corp. ( CVM After carefully evaluating all relevant scientific evidence, investor presentations, and arguments from both sides, the author estimates CVM has an 85% chance of witnessing trial success in Multikine and will likely ten-bag if so. On the other hand, there is a 15% probability that the company may fail its investigation and see shares go to zero. The author believes the risks to be worth taking due to a high expected value, and presents below as to why this is the case. The Bear Case When more complete studies were available (regarding IL-2), complete responses to this regimen in Show less Read more
Impact Snapshot
Event Time:
CVM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
CVM alerts

from News Quantified
Opt-in for
CVM alerts

from News Quantified